Omkrown Pharam-Chem Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
as on 03-07-2024
- Paid Up Capital ₹ 4.00 M
as on 03-07-2024
- Company Age 30 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.50 Cr
as on 03-07-2024
- Satisfied Charges ₹ 2.17 Cr
as on 03-07-2024
- Revenue 63.38%
(FY 2023)
- Profit 203.15%
(FY 2023)
- Ebitda 231.57%
(FY 2023)
- Net Worth 7.81%
(FY 2023)
- Total Assets -12.28%
(FY 2023)
About Omkrown Pharam-Chem
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 4.00 M.
The company currently has active open charges totaling ₹1.50 Cr. The company has closed loans amounting to ₹2.17 Cr, as per Ministry of Corporate Affairs (MCA) records.
Tejasvi Anavekar, Vinayak Anavekar, and Rajesh Anavekar serve as directors at the Company.
- CIN/LLPIN
U24290KA1994PTC016598
- Company No.
016598
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Nov 1994
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Nagar, Shahapur, Belgaum, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Omkrown Pharam-Chem Private Limited offer?
Omkrown Pharam-Chem Private Limited offers a wide range of products and services, including Potassium Salts, Potassium Phthalimide.
Who are the key members and board of directors at Omkrown Pharam-Chem?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Tejasvi Anavekar  | Director | 02-Dec-2010 | Current |
| Vinayak Anavekar | Director | 23-Nov-1994 | Current |
| Rajesh Anavekar | Director | 24-Jun-2022 | Current |
Financial Performance of Omkrown Pharam-Chem.
Omkrown Pharam-Chem Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 63.38% increase. The company also saw a substantial improvement in profitability, with a 203.15% increase in profit. The company's net worth moved up by a moderate rise of 7.81%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Omkrown Pharam-Chem?
In 2023, Omkrown Pharam-Chem had a promoter holding of 63.00% and a public holding of 37.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 28 May 2020 | ₹1.50 Cr | Open |
Bank Of India Creation Date: 10 Mar 2014 | ₹1.10 Cr | Satisfied |
Bank Of India Creation Date: 03 Mar 2006 | ₹1.07 Cr | Satisfied |
How Many Employees Work at Omkrown Pharam-Chem?
Unlock and access historical data on people associated with Omkrown Pharam-Chem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Omkrown Pharam-Chem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Omkrown Pharam-Chem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
